IDEXX Laboratories Inc banner

IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 567.46 USD 1.19% Market Closed
Market Cap: $45.1B

EV/IC

14.9
Current
4%
Cheaper
vs 3-y average of 15.5

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
14.9
=
Enterprise Value
$51.4B
/
Invested Capital
$3.1B

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
14.9
=
Enterprise Value
$51.4B
/
Invested Capital
$3.1B

Valuation Scenarios

IDEXX Laboratories Inc is trading below its 3-year average

If EV/IC returns to its 3-Year Average (15.5), the stock would be worth $590.97 (4% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-90%
Maximum Upside
+9%
Average Downside
41%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 14.9 $567.46
0%
3-Year Average 15.5 $590.97
+4%
5-Year Average 16.2 $616.13
+9%
Industry Average 1.9 $72.83
-87%
Country Average 1.5 $56.69
-90%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close

Market Distribution

Higher than 93% of companies in the United States of America
Percentile
93rd
Based on 11 657 companies
93rd percentile
14.9
Low
0 — 0.9
Typical Range
0.9 — 2.9
High
2.9 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 0.9
Median 1.5
70th Percentile 2.9
Max 566 432.7

IDEXX Laboratories Inc
Glance View

IDEXX Laboratories Inc. stands as a pillar of innovation in the realm of veterinary diagnostics, transforming the landscape of animal healthcare. Founded in 1983, the company has strategically positioned itself at the intersection of science and care, delivering a broad range of products and services that cater primarily to veterinarians. By offering state-of-the-art diagnostic tests and in-house laboratory equipment, IDEXX empowers veterinarians to make precise and timely decisions. These tools not only enhance animal health but also streamline veterinary practices, allowing them to offer clients rapid, reliable results. By investing heavily in research and development, IDEXX continuously enhances its product portfolio, maintaining a competitive edge in a market that demands constant innovation. In addition to its core veterinary diagnostic services, IDEXX extends its expertise into water testing and livestock and poultry diagnostics, though these segments are smaller. The company crafts its revenue model on providing recurring, subscription-based services for its diagnostic machines, which require regular updating with new test kits and consumables. This model ensures a durable revenue stream, fostering long-term relationships with veterinary clinics worldwide. As digital transformation sweeps through every industry, IDEXX has also embraced the digital age, crafting sophisticated software that aids veterinarians in managing their practices more efficiently, thus augmenting its revenue through IT solutions. This diversified yet synergistic approach has allowed IDEXX to remain resilient and grow steadily, delivering consistent value to both its clients and shareholders.

IDXX Intrinsic Value
265.44 USD
Overvaluation 53%
Intrinsic Value
Price $567.46
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett